Drug Type CAR-T  | 
Synonyms-  | 
Target  | 
Action inhibitors  | 
Mechanism BCMA inhibitors(B-cell maturation protein inhibitors), SLAMF2 inhibitors(Cluster of differentiation 48 inhibitors)  | 
Therapeutic Areas  | 
Active Indication  | 
Inactive Indication-  | 
Originator Organization  | 
Active Organization  | 
Inactive Organization-  | 
License Organization-  | 
Drug Highest PhasePreclinical  | 
First Approval Date-  | 
Regulation-  | 
| Indication | Highest Phase | Country/Location | Organization | Date | 
|---|---|---|---|---|
| Neoplasms | Preclinical | China   | 16 Apr 2024 | 





